conf-2019

Register here:  https://autismone.ticketspice.com/autism-one-2019-conference

The most rewarding educational and networking experience you can have at any autism conference!  An exceptional value as you gather new hope, answers, help, and direction.

New to the autism diagnosis? Come hear the “Newly Diagnosed” track just for you!
Yearning to learn more? Hear the “Biomedical Research and Treatments” track!

This conference will help you answer and understand important concepts:

  • Recovery from autism is possible and children get better!
  • There are medical comorbidities of autism that, when treated, allow the child to enjoy improved learning and behavior.

On the autism journey a little while? Come hear the latest research and healing information!
Medical professional? Hear renowned researchers present the latest cutting-edge autism research.

Conference track highlights include:
  • Membrane Medicine track
  • PANDAS/PANS track (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome)
  • 4th Annual International HPV Vaccine Education Symposium
  • Focus for Health Advocacy Training track
  • Chiropractic Pediatric Continuing Education Credit Program with Emphasis on Autism
  • Endocannabinoid Medicine track
  • ADHD (attention-deficit/hyperactivity disorder) track
  • Culinary Day: Culinary Day on a Budget
  • And a special surprise panel that illuminates the bigger picture that affects your family’s world

The AutismOne 2019 Conference will be held May 22-26, 2019, at the Loews Chicago O’Hare Hotel in Rosemont, IL.

“AutismOne always has the cutting-edge information years ahead of any other autism conference. You hear it first at AutismOne.” ~Janet Cakir, PhD

CONFERENCE SCHEDULE-AT-A-GLANCE

WEDNESDAY, MAY 22, LECTURES:
1:30PM-6:00PM

THURSDAY, MAY 23, LECTURES, MOVIES, PANELS:
8:30AM-10:15PM

FRIDAY, MAY 24, LECTURES AND PANELS:
8:30AM-5:45PM

SATURDAY, MAY 25, LECTURES AND PANELS:
8:30AM-7:00PM

SUNDAY, MAY 26, LECTURES:
8:45AM-1:30PM

See list of speakers:  https://autismoneconference.com/conference_speakers.html  Erica Linn, MSN & Dr. Greg Brown MD from Serenity Health in Wisconsin will be speakers at the conference.  Dr. Brown treats children and adults with Lyme/MSIDS as well as PANS/PANDAS.  He’s stated that up to 80% of his autistic and PANS/PANDAS patients are infected with Lyme/MSIDS.

For more on that connection:  https://madisonarealymesupportgroup.com/2017/10/01/panspandas-steroids-autoimmune-disease-lymemsids-the-need-for-medical-collaboration/

https://madisonarealymesupportgroup.com/2017/10/08/misdiagnosed-how-children-with-treatable-medical-issues-are-mistakenly-labeled-as-mentally-ill/

https://madisonarealymesupportgroup.com/2017/06/30/child-with-lymemsidspans-told-by-doctors-she-made-it-all-up/

https://madisonarealymesupportgroup.com/2017/10/09/today-is-panspandas-awareness-day/  Trifiletti officially diagnosed Carson with PANS, not PANDAS, due to the active co-infections found in his blood work: mycoplasma, the bacteria that causes pneumonia; coxsackie — the virus causing Hand, Foot and Mouth disease; streptococcus, the bacteria causing strep throat; bartonella and babesia — a bacteria and parasite related to Lyme disease; and yeast, Melissa Spears said.

Instead of attacking these infections, Carson’s antibodies were instead going after his brain.

https://madisonarealymesupportgroup.com/2018/03/14/dr-frid-children-lyme/

https://buffalonews.com/2019/03/24/jacobs-calls-for-1-million-in-state-budget-to-battle-lyme-disease/?

Jacobs calls for $1 million in state budget to battle Lyme disease

 

State Sen. Chris Jacobs (NY) is calling for Gov. Cuomo and Assembly leaders to support $1 million in the state budget to help fight Lyme disease and other tick-borne diseases.

Jacobs said about 9,000 cases of Lyme and other tick-borne diseases are reported to the state Health Department each year.

“Clearly more resources need to be committed to bolster education, prevention and research initiatives,” Jacobs said.

Jacobs is also advocating for support of a package of bills to fight Lyme and other tick-borne diseases.

https://restorativemedicine.org/wp-content/uploads/2017/01/4Holtorf_-Lyme-CFS.pdf  (Slides Found in link)

iu-7

Innovative “Alternative” Therapies for Chronic Lyme Disease

Kent Holtorf, M.D.

Holtorf Medical Group National Academy of Hypothyroidism Kholt@holtorfmed.com

 

 

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006095.pub4/abstract

Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children

Abstract

Background

Antibiotics can disturb gastrointestinal microbiota which may lead to reduced resistance to pathogens such as Clostridium difficile (C. difficile). Probiotics are live microbial preparations that, when administered in adequate amounts, may confer a health benefit to the host, and are a potential C. difficile prevention strategy. Recent clinical practice guidelines do not recommend probiotic prophylaxis, even though probiotics have the highest quality evidence among cited prophylactic therapies.

Objectives

To assess the efficacy and safety of probiotics for preventing C.difficile‐associated diarrhea (CDAD) in adults and children.

Search methods

We searched PubMed, EMBASE, CENTRAL, and the Cochrane IBD Group Specialized Register from inception to 21 March 2017. Additionally, we conducted an extensive grey literature search.

Selection criteria

Randomized controlled (placebo, alternative prophylaxis, or no treatment control) trials investigating probiotics (any strain, any dose) for prevention of CDAD, or C. difficile infection were considered for inclusion.

Data collection and analysis

Two authors (independently and in duplicate) extracted data and assessed risk of bias. The primary outcome was the incidence of CDAD. Secondary outcomes included detection of C. difficile infection in stool, adverse events, antibiotic‐associated diarrhea (AAD) and length of hospital stay. Dichotomous outcomes (e.g. incidence of CDAD) were pooled using a random‐effects model to calculate the risk ratio (RR) and corresponding 95% confidence interval (95% CI). We calculated the number needed to treat for an additional beneficial outcome (NNTB) where appropriate. Continuous outcomes (e.g. length of hospital stay) were pooled using a random‐effects model to calculate the mean difference and corresponding 95% CI. Sensitivity analyses were conducted to explore the impact of missing data on efficacy and safety outcomes. For the sensitivity analyses, we assumed that the event rate for those participants in the control group who had missing data was the same as the event rate for those participants in the control group who were successfully followed. For the probiotic group, we calculated effects using the following assumed ratios of event rates in those with missing data in comparison to those successfully followed: 1.5:1, 2:1, 3:1, and 5:1. To explore possible explanations for heterogeneity, a priori subgroup analyses were conducted on probiotic species, dose, adult versus pediatric population, and risk of bias as well as a post hoc subgroup analysis on baseline risk of CDAD (low 0% to 2%; moderate 3% to 5%; high > 5%). The overall quality of the evidence supporting each outcome was independently assessed using the GRADE criteria.

Main results

Thirty‐nine studies (9955 participants) met the eligibility requirements for our review. Overall, 27 studies were rated as either high or unclear risk of bias. A complete case analysis (i.e. participants who completed the study) among trials investigating CDAD (31 trials, 8672 participants) suggests that probiotics reduce the risk of CDAD by 60%. The incidence of CDAD was 1.5% (70/4525) in the probiotic group compared to 4.0% (164/4147) in the placebo or no treatment control group (RR 0.40, 95% CI 0.30 to 0.52; GRADE = moderate). Twenty‐two of 31 trials had missing CDAD data ranging from 2% to 45%. Our complete case CDAD results proved robust to sensitivity analyses of plausible and worst‐plausible assumptions regarding missing outcome data and results were similar whether considering subgroups of trials in adults versus children, inpatients versus outpatients, different probiotic species, lower versus higher doses of probiotics, or studies at high versus low risk of bias. However, in a post hoc analysis, we did observe a subgroup effect with respect to baseline risk of developing CDAD. Trials with a baseline CDAD risk of 0% to 2% and 3% to 5% did not show any difference in risk but trials enrolling participants with a baseline risk of > 5% for developing CDAD demonstrated a large 70% risk reduction (interaction P value = 0.01). Among studies with a baseline risk > 5%, the incidence of CDAD in the probiotic group was 3.1% (43/1370) compared to 11.6% (126/1084) in the control group (13 trials, 2454 participants; RR 0.30, 95% CI 0.21 to 0.42; GRADE = moderate). With respect to detection of C. difficile in the stool pooled complete case results from 15 trials (1214 participants) did not show a reduction in infection rates. C. difficile infection was 15.5% (98/633) in the probiotics group compared to 17.0% (99/581) in the placebo or no treatment control group (RR 0.86, 95% CI 0.67 to 1.10; GRADE = moderate). Adverse events were assessed in 32 studies (8305 participants) and our pooled complete case analysis indicates probiotics reduce the risk of adverse events by 17% (RR 0.83, 95% CI 0.71 to 0.97; GRADE = very low). In both treatment and control groups the most common adverse events included abdominal cramping, nausea, fever, soft stools, flatulence, and taste disturbance.

Authors’ conclusions

Based on this systematic review and meta‐analysis of 31 randomized controlled trials including 8672 patients, moderate certainty evidence suggests that probiotics are effective for preventing CDAD (NNTB = 42 patients, 95% CI 32 to 58). Our post hoc subgroup analyses to explore heterogeneity indicated that probiotics are effective among trials with a CDAD baseline risk >5% (NNTB = 12; moderate certainty evidence), but not among trials with a baseline risk ≤5% (low to moderate certainty evidence). Although adverse effects were reported among 32 included trials, there were more adverse events among patients in the control groups. The short‐term use of probiotics appears to be safe and effective when used along with antibiotics in patients who are not immunocompromised or severely debilitated. Despite the need for further research, hospitalized patients, particularly those at high risk of CDAD, should be informed of the potential benefits and harms of probiotics.

 

What is Clostridium difficile‐associated diarrhea?

Antibiotics are among the most prescribed medications worldwide. Antibiotic treatment may disturb the balance of organisms that normally populate the gut. This can result in a range of symptoms, most notably, diarrhea. Clostridium difficile (C. difficile) is a particularly dangerous organism that may colonize the gut if the normal healthy balance has been disturbed. Clostridium difficile‐related disease varies from asymptomatic infection, diarrhea, colitis, and pseudo‐membranous colitis to toxic megacolon and death. The cost of treatment is expensive and the financial burden on the medical system is substantial.

What are probiotics?

Probiotics are live organisms (bacteria or yeast) thought to improve the balance of organisms that populate the gut, counteracting potential disturbances to the gut microbial balance that are associated with antibiotic use, and reducing the risk of colonization by pathogenic bacteria. Probiotics can be found in dietary supplements or yogurts and are becoming increasingly available as capsules sold in health food stores and supermarkets. As ‘functional food’ or ‘good bacteria’, probiotics have been suggested as a means of both preventing and treating C. difficile‐associated diarrhea (CDAD).

What did the researchers investigate?

The researchers investigated whether probiotics prevent CDAD in adults and children receiving antibiotic therapy and whether probiotics causes any harms (side effects). The researchers searched the medical literature extensively up to 21 March 2017.

What did the researchers find?

This review includes 39 randomized trials with a total of 9955 participants. Thirty‐one studies (8672 participants) assessed the effectiveness of probiotics for preventing CDAD among participants taking antibiotics. Our results suggest that when probiotics are given with antibiotics the risk of developing CDAD is reduced by 60% on average. Among trials enrolling participants at high risk of developing CDAD (> 5%), the potential benefit of probiotics is more pronounced with a 70% risk reduction on average. Side effects were assessed in 32 studies (8305 participants) and our results suggest that taking probiotics does not increase the risk of developing side effects. The most common side effects reported in these studies include abdominal cramping, nausea, fever, soft stools, flatulence, and taste disturbance. The short‐term use of probiotics appears to be safe and effective when used along with antibiotics in patients who are not immunocompromised or severely debilitated. Despite the need for further research, hospitalized patients, particularly those at high risk of CDAD, should be informed of the potential benefits and harms of probiotics.

How to Grieve Your Life Before Lyme Disease

We can get so caught up in treatments and pressing forward that the topic of Self-Grief, (the process of grieving your “former” self) is a rarely spoken about issue within the Lyme Disease, Chronic Pain and Illness communities. Many people frequently experience hardship over not feeling like their self that they used to be. They cannot do the same hobbies, have the same friends, etc. However, if you allow yourself to go on this journey of self-grieving; you often will end up learning your own goals and true self better than you ever could imagine.

1.       Allow your mind time to catch up to what your body is going through and has gone through.

Did you have a full-time job? Were you in school to finish a degree? Could you shower, put on makeup, get dressed and STILL have energy to go out or socialize? Me too. The changes that happen when serious illness enters your life is a whirlwind of loss to say the least. As if a category 5 hurricane crashed through every single life plan and goal that was once laid out before you, it takes time to come to grips with the losses and to establish a course of action. Don’t expect yourself to be able to process all of these at once. It will come in waves, ride them instead of bracing for impact.

2.       Accept limitations without settling for less.

Living with limitations does NOT mean a life half empty. It may take you longer to complete a mentally draining task, but you can do it. You may need assistance with walking, driving, or even self-care but at the end of the day you are not doing less…in fact, you are doing more because you have to now learn how to achieve all of those check marks by your to do list (even if it’s a mental list) in a totally new fashion. Accepting your difference will never make you less than another, it only empowers you to reach your goals by whatever means necessary.

3.       Avoid romanticizing your time before illness.

This is a BIG one and honestly one of the hardest for me. We’ve all heard those stories about the “good ole days”. The good ole days of someone’s football triumphs, crazy parties and cross-country love affairs make for great Netflix specials but are often far from reality. However, they serve as great examples of what not to do. Think about it, when you see characters that do these rose-colored glasses reminiscing, they are not typically the most fulfilled individuals nor the most cheerful. Putting a version of yourself or even a time period in your life on a pedestal only breeds bitterness and strife. We can remember fondly times before disease raised its ugly head but allowing thought patterns to form saying “the good days are behind us” only gives depression, angst and hopelessness take root.

4.       Set new achievable goals.

Is there a book you’ve always wanted to read? What about a topic that has always peaked interest? After facing the reality of your own mortality, there is a certain freedom that follows. The societal norms get pushed aside and you are truly free to do and be whatever it is that you desire. Grow how you want to grow, heal what wounds your heart tries to hide, embrace life in all its sublimity. The possibilities are endless. So, what if you physically can’t climb Mt. Everest! Most people can’t. You have your own Mt. Everest within you…start climbing!

5.       Understand and forgive that most people will not be able to comprehend what you have experienced.

“You don’t get it until you’ve got it.” One of my Lymie friends says that all the time and I love it! Because it is so very true! Think of how hard it would be to explain the sunset to someone that is blind. Or what a flower smells like to someone who cannot smell. (I had a friend that couldn’t smell, its hard to do…trust me). The same goes for life with Lyme Disease. No one else will ever fully understand the struggle of having doctors turn you away or feeling like your body has turned against you. Good luck explaining how you miss yourself to someone that has never walked that dark and terrifying path. But that is why we have a community like this in place. We know. We have been there. We are still there. Forgive those that don’t understand. They won’t get it until they have it.

6.       Dream a new dream for YOU!

Just because the life you dreamed of didn’t play out doesn’t mean you cannot develop a new dream. Guess what, most people have multiple dreams in a lifetime. You may feel like it is too late in life to start dreaming and reaching for a new purpose; but it is never too late! We never stop growing as people and should never stop learning. Why not carry that on into your life path too?

7.       Release your bottled-up emotions.

Cry, scream, break cheap plates you buy from a thrift store. ANYTHING! Those feelings of guilt and pain flow especially well when breaking things. Don’t ask me how I know, I just know. You don’t always have to be the strong one, the inspiring one, the funny girl or guy. If you are sad, be sad. It really is that simple. We were given emotions in order to feel and connect to the reality around us; to experience life in all its majestic chaos.

8.       Get involved with your fellow warriors.

Want to feel a sense of purpose again? Missing that social interaction you use to feel when you were able to be a “functioning member” of society? Open up about your struggles. Reach out to other Lyme Warriors and Pain Warriors. When you form a connection based upon using your pain for power, you will see that your story is so powerful. Even if you don’t want to go public about your journey, simply reaching out to someone that is struggling can be a great source of personal achievement and satisfaction. If you are a real go-getter, my fellow over achieving warriors, get involved in a nonprofit organization. Take up donations for a charity. Watch that goofy live feed, share the fundraising events, comment and let a writer know you enjoyed their piece. There are so many ways (big and small) that you can get involved and spread some love.

9.       Learn to love yourself and your body in the present condition.

Instead of the running narrative in your mind (and possibly out loud) that “my body hates me”, “my immune system is weak”, “this will never change”, “I will always be in pain”, or even “I can’t do this anymore”; fill your mental space will reassurance, love and acceptance. Your body doesn’t hate you. Your immune system truly is doing the best it possibly can and just needs your help. This is the only physical form we are given and therefore our one true and original ally in this fight for survival. Your body is already under attack for a large majority of the day, don’t allow your own mental consciousness to become another battle for it to wage. Become your own ally. Take medications, meditate, eat healthy foods and nurture yourself.

10.   This one is up to you!

This is no one else’s journey but yours. At the end of the day, you are the one that holds the only power in this situation. Yes, not even your disease is more powerful than the essence of you. While disease may wreck our bodies, YOU are still in there. Your essence, soul, spirit remains regardless of the physical shell it inhabits. So, we here at Lyme Warrior want to hear what additional steps you are taking to make this chapter your new “good ole days” story origin.